Panel Discussion: How to Monitor and Minimize Variation and Mistakes (Clinical Chemistry Forum) (Discussion)
Clinical Chemistry 1997, May, 43, 5
-
- £2.99
-
- £2.99
Publisher Description
Panel II of the 1996 Clinical Chemistry Forum was a discussion initiated by brief formal presentations from Rosemary Bakes-Martin of the US Centers for Disease Control and Prevention (CDC), Cornelia Rooks of the US Food and Drug Administration (FDA), William Hamlin of the College of American Pathologists (CAP), Nathan Gochman of Beckman Instruments, and David Witte of this Forum Committee. Initial Presentations
GENRE
Science & Nature
RELEASED
1997
1 May
LANGUAGE
EN
English
LENGTH
19
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SIZE
192.5
KB
Quality: The Next Six Months (Clinical Chemistry Forum)
1997
Principles and Practice of Clinical Research
2017
Analytical Performance Characteristics should be Judged Against Objective Quality Specifications (Editorial)
1999
Quality Assurance
2013
Laboratory Medicine: Challenges and Opportunities (Opinion)
2007
Pharmaceutical Analysis for Small Molecules
2017
Single-Nucleotide Polymorphism Allele Frequencies Determined by Quantitative Kinetic Assay of Pooled Dna (Technical Briefs)
2002
Interlaboratory Comparison of Fetal Male DNA Detection from Common Maternal Plasma Samples by Real-Time Pcr (Molecular Diagnostics and Genetics)
2004
High Concentrations of Excised Oxidative DNA Lesions in Human Cerebrospinal Fluid (Technical Briefs)
2003
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Relationship Between Genetic Polymorphisms of Alcohol-Metabolizing Enzymes and Changes in Risk Factors for Coronary Heart Disease Associated with Alcohol Consumption (Lipids, Lipoproteins, And Cardiovascular Risk Factors)
2002
Detection of Mycobacterium Tuberculosis by Real-Time PCR Using Pan-Mycobacterial Primers and a Pair of Fluorescence Resonance Energy Transfer Probes Specific for the M. Tuberculosis Complex (Technical Briefs)
2003